Systemic Anti-Cancer Therapy Scheduler

PLEASE NOTE THE POST HOLDER WILL BE BASED AT TAMESIDEThe SACT team require a scheduler to work as part of our existing team to schedule patients receiving Systemic anti-cancer treatments. The post holder will be based at Tameside and primarily supporting the haematology services.The post holder will be expected to work as part of a very busy team, spending time in outpatient clinics and may support other administration roles.The post holder will require excellent communication skills and be able to work as part of a team but also be able to manage your own workload. The role requires considerable amount of computer work using a few of the trusts systems. A good knowledge of these information systems would be an advantage, although training will be given., The post holder's role will include the booking of patients SACT treatment, and booking Outpatients appointments, communicating with patients and relatives both face to face and on the phone, ensuring patients receive their appointments in a timely manner. Other administration skills will be required.The role requires the individual to meet deadlines for appointments and targets, to communicate well with all members of the multidisciplinary team, patients, and their relatives and to act in a professional, courteous manner at all times.The successful candidate would be expected to work a variety of shifts between 7.30am and 6pm throughout the week. There will also be an expectation to work some Bank Holidays and Saturdays on rotation.

The Christie is one of Europe's leading cancer centres, looking after more than 64,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 25% patients are referred to us from other parts of the country.

We are the largest radiotherapy provider in the NHS with one in 20 treatments delivered at The Christie. We have up to 15 linear accelerators operating across our network of sites. We operate the largest chemotherapy unit in the UK on our main site and treatments are also provided at 13 other networked sites, and in patients homes. And as a specialist tertiary surgical centre, we focus on rare cancers, complex procedures, and multidisciplinary approaches to cancer surgery, specialising in colorectal, peritoneal, gynaecological, urological and plastic surgery.

We are also an international leader in research, with world first breakthroughs for over 100 years. We have been named by the UK's National Institute for Health Research (NIHR), as one of the best hospitals providing opportunities for patients to participate in clinical research studies, with more than 800 studies open at any time, caring for over 3,000 patients.